We are live on ! Find out more
WINT

Windtree Therapeutics
WINT

Delisted

WINT was delisted on the 20th of August, 2025.

Back to rankings

14 hedge funds and large institutions have $3.94M invested in Windtree Therapeutics in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

56% more funds holding

Funds holding: 9 → 14 (+5)

45% more capital invested

Capital invested by funds: $2.72M → $3.94M (+$1.23M)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
14
Holders Change
+5
Holders Change %
+55.56%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
–
Closed
3
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$292K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$195K
3
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$195K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$195K
5
BlackRock
BlackRock
New York
+$97.3K

Top Sellers

Rank Fund Capital Flow
1
AAA
Affinity Asset Advisors
New York
-$105K
2
Citadel Advisors
Citadel Advisors
Florida
-$97.3K
3
HF
HRT Financial
New York
-$57K
4
SFS
Sowell Financial Services
Arkansas
-$9K

WINT Hedge Fund Activity: Q2 2021 in Review

14 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics (WINT) for Q2 2021, worth a combined $3.94M — up 45% from $2.72M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new WINT positions and 3 closed out — a net gain of 5 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $292K. The largest seller was Affinity Asset Advisors, exiting entirely with an estimated $105K sold.

  • 14 institutional investors held Windtree Therapeutics (WINT) as of Q2 2021, up from 9 in Q1 2021.
  • Funds reported $3.94M of Windtree Therapeutics stock for Q2 2021, up 45% quarter-over-quarter.
  • 8 funds opened new Windtree Therapeutics positions in Q2 2021 and 3 closed out, a net change of +5 holders.
  • The largest Windtree Therapeutics buyer in Q2 2021 was Renaissance Technologies, an estimated $292K added.
  • The largest Windtree Therapeutics seller in Q2 2021 was Affinity Asset Advisors, an estimated $105K sold.

Based on aggregated 13F filings for Q2 2021.